The line between cosmetics, cosmeceuticals, and clinical treatments continues to blur, and the legal and regulatory challenges facing both manufacturers and medspa operators are growing increasingly complex

Our panelists will examine the unique regulatory and contractual considerations that arise when professional-use cosmetics and skincare products are marketed, labeled, and sold into medspas, massage clinics, and other treatment environments.

• Examining where the FDA and FTC draw the line between cosmetics, cosmeceuticals, and drugs
• Understanding the key labeling and distribution requirements specific to professional-use cosmetics
• Analyzing enforcement trends targeting medspas and clinics for aggressive or unsupported product claims
• Obtaining practical guidance on contractual protections for manufacturers selling to medspas or through wholesale channels
• Highlighting NAD scrutiny and FTC advertising risks when claims are made by third-party service providers
• How to respond when clinics ask: “Are we regulated the same way as you?”